O2‐11‐02: Comparison of All‐Cause Mortality Rate and Economic Burden Between Newly Diagnosed Alzheimer's Disease Patients Who Received Anti‐Dementia Treatment Versus Not: A Longitudinal Retrospective Study | Zendy

Black Christopher M. | Zendy; Hu Xiaohan | Zendy; Khandker Rezaul Karim | Zendy; Ambegaonkar Baishali M. | Zendy; Kariburyo Furaha | Zendy; Xie Lin | Zendy; Baser Onur | Zendy; Yuce Huseyin | Zendy

Premium

O2‐11‐02: Comparison of All‐Cause Mortality Rate and Economic Burden Between Newly Diagnosed Alzheimer's Disease Patients Who Received Anti‐Dementia Treatment Versus Not: A Longitudinal Retrospective Study

Author(s) -

Black Christopher M.,

Hu Xiaohan,

Khandker Rezaul Karim,

Ambegaonkar Baishali M.,

Kariburyo Furaha,

Xie Lin,

Baser Onur,

Yuce Huseyin

Publication year - 2016

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2016.06.455

Subject(s) - medicine , rivastigmine , galantamine , dementia , donepezil , hazard ratio , retrospective cohort study , proportional hazards model , population , national death index , diagnosis code , propensity score matching , disease , pediatrics , confidence interval , environmental health

O2-11-02 COMPARISON OFALL-CAUSEMORTALITY RATE AND ECONOMIC BURDEN BETWEEN NEWLY DIAGNOSED ALZHEIMER’S DISEASE PATIENTS WHO RECEIVED ANTI-DEMENTIATREATMENT VERSUS NOT: A LONGITUDINAL RETROSPECTIVE STUDY Christopher M. Black, Xiaohan Hu, Rezaul Karim Khandker, Baishali M. Ambegaonkar, Furaha Kariburyo, Lin Xie, Onur Baser, Huseyin Yuce, Merck&Co., Inc., Kenilworth, NJ, USA; Temple University, Philadelphia, PA, USA; 3 STATinMED Research, Ann Arbor, MI, USA; Center for Innovation&Outcomes Research, Department of Surgery, New York, NY, USA; New York City College of Technology, Brooklyn, NY, USA. Contact e-mail: xiaohan.hu@merck.com

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research